Immunoassays for Carcinoembryonic antigen: Specificity and interferences

References

• Gold P, Freedman S O. Demonstration of tumor-specific antigens in human carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439–62
   PubMed Web of Science ®Google Scholar
• Thomson D MP, Krupey J, Freedman S O., Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 1969; 64: 161–7
   PubMed Web of Science ®Google Scholar
• Zamcheck N, Moore T L., Dhar P, Kupchik H. Immunologic diagnosis and prognosis of human digestive-tract cancer: Carcinoembryonic antigens. New Engl J Med 1972; 286: 83–6
   PubMed Web of Science ®Google Scholar
• Thompson J, Zimmermann W. The carcinoembryonic antigen gene family: Structure, expression and evolution. Tumor Biol 1988; 9: 63–83
   PubMed Web of Science ®Google Scholar
• Thompson J A., Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344–66
   PubMed Web of Science ®Google Scholar
• Hefta S A., Hefta L JF, Lee T D., Paxton R J., Shively J E. Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: Identification of the ethanolamine linkage site. Proc Natl Acad Sci USA 1988; 85: 4648–52
   PubMedGoogle Scholar
• Paxton R J., Mooser G, Pande H, Lee T D., Shively J E. Sequence analysis of carcinoembryonic antigen: Identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci USA 1987; 84: 920–4
   PubMed Web of Science ®Google Scholar
• von Kleist S, Chavanel G, Burtin P. Identification of an antigen from normal human tissue that cross-reacts with the carcinoembryonic antigen. Proc Natl Acad Sci USA 1972; 69: 2492–4
   PubMedGoogle Scholar
• Burtin P, Quan P C., Sabine M C. Nonspecific cross-reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature 1975; 255: 714–6
   Google Scholar
• Kuroki M, Matsuo Y, Ohtani T, Minowada J, Matsuoka Y. A novel CEA-cross-reacting antigen of molecular weight 140,000 expressed on human lymphoid cell lines. Mol Immunol 1990; 27: 689–96
   PubMed Web of Science ®Google Scholar
• Svenberg T. Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization. Int J Cancer 1976; 17: 588–96
   PubMed Web of Science ®Google Scholar
• Burtin P, Chavanel G, Hirsch-Marie H. Characterization of a second normal antigen that cross-reacts with CEA. J Immunol 1973; 111: 1926–8
   Google Scholar
• Neumaier M, Fenger U, Wagener C. Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: Identification of two novel CEA-related antigens in meconium and colorectal cancer tissue by western blots and differential immunoaffinity chromatography. J Immunol 1985; 135: 3604–9
   PubMed Web of Science ®Google Scholar
• Suzuki N, Kondo K, Tominaga S, Kuroki M, Matsouka Y. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities. Cancer Res 1987; 47: 4782–7
   PubMedGoogle Scholar
• Grunert F, Abu Harfeil N, Schwarz K, von Kleist S. Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns. Int J Cancer 1985; 36: 357–62
   PubMed Web of Science ®Google Scholar
• Hedin A, Hammarström S, Svenberg T, Sundblad G. Low molecular weight CEA, isolation and characterization. Scand J Immunol 1978; 8: 423–8, Suppl 8
   Google Scholar
• Hefta S A., Paxton R J., Shively J E. Protein structural analysis of members of the carcinoembryonic antigen gene family (Abstract). Tumor Biol 1990; 11: 68
   Google Scholar
• Börmer O P. Major disagreement between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2). Clin Chem 1991; 37: 1736–9
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Matsuo Y, Sugano K, Ohkura H, Kuroki Mo, Kuroki Ma. Characterization of carcinoembryonic antigen-related antigens in normal adult feces. Jpn J Cancer Res 1990; 81: 514–9
   PubMedGoogle Scholar
• Hammarstrom S, Shively J E., Paxton R J., Beatty B G., Larsson Å, Ghosh R, Börmer O, Buchegger F, Mach J-P, Burtin P, Seguin P, Darbouret B, Degorce F, Sertour J, Jolu J P., Fuks A, Kalthoff H, Schmiegel W, Arndt R, Kloppel G, von Kleist S, Grunert F, Schwarz K, Matsuoka Y, Kuroki M, Wagener C, Weber T, Yachi A, Imai K, Hishikawa N, Tsujisaki M. Antigenic sites in carcinoembryonic antigen. Cancer Res 1989; 49: 4852–8
   PubMed Web of Science ®Google Scholar
• Nap M, Hammarström M-L, Börmer O P., Hammarström S, Wagener C, Handt S, Schreyer M, Mach J-P, Buchegger F, von Kleist S, Grunert F, Seguin P, Fuks A, Holm R, Lamerz R. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res 1992; 52: 2329–39
   PubMed Web of Science ®Google Scholar
• Thomas P, Toth C A., Saini K S., Jessup J M., Steele G, Jr. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990; 1032: 177–89
   PubMedGoogle Scholar
• Nap M, Mollgard K, Burtin P, Fleuren G J. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumor Biol 1988; 9: 145–53
   PubMedGoogle Scholar
• Wick M R. Monoclonal antibodies to carcinoembryonic antigen in diagnostic immunohistochemistry. Monoclonal Antibodies in Diagnostic Immunohistochemistry, M R. Wick, G P. Siegal. Marcel Dekker, New York, Basel 1988; 539–67
   Google Scholar
• Rognum T O., Thorud E, Elgjo K, Brandtzsg P, Ørjasæter H, Nygaard K. Large-bowel carcinomas with different ploidy, related to secretory component, IgA and CEA in epithelium and CEA in plasma. Br J Cancer 1982; 45: 921–33
   PubMed Web of Science ®Google Scholar
• Fischbach W, Mossner J, Seyschab H, Höhn H. Tissue carcinoembryonic antigen and DNA aneuploidy in precancerous and cancerous colorectal lesions. Cancer 1990; 65: 1820–4
   PubMed Web of Science ®Google Scholar
• Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners C P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989; 57: 327–34
   PubMed Web of Science ®Google Scholar
• Jessup J M., Thomas P. Carcinoembryonic antigen: Function in metastasis by human colorectal carcinoma. Cancer Metast Rev 1989; 8: 263–80
   PubMedGoogle Scholar
• Leusch H-G, Hefta S A., Drzeniek Z, Hummel K, Markos-Pusztai Z, Wagener C. Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett 1990; 261: 405–9
   Google Scholar
• National Institutesof Health Consensus Statement. Carcinoembryonic antigen: its role as a marker in the management of cancer. Br Med J 1981; 282: 373–5
   Google Scholar
• Tate H. Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br J Cancer 1982; 46: 323–30
   PubMed Web of Science ®Google Scholar
• Minton J P., Hoehn J L., Gerber D M., Horsley J S., Connolly D P., Salwan F, Fletcher W S., Cruz A B., Gatchell F G., Oviedo M, Meyer K K., Leffall L D., Berk R S., Stewart P A., Kurucz S E. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284–90
   PubMed Web of Science ®Google Scholar
• Kievit J, van deVelde C JH. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis. Cancer 1990; 65: 2580–7
   PubMed Web of Science ®Google Scholar
• Tate H. Assessing tumor markers. Br J Cancer 1981; 44: 643–51
   Google Scholar
• Sikorska H, Shuster J, Gold P. Clinical applications of carcinoembryonic antigen. Cancer Det Prev 1988; 12: 321–55
   PubMedGoogle Scholar
• Minton J P., Chevinsky A. Present status of serum markers. Sem Surg Oncol 1989; 5: 426–35
   PubMedGoogle Scholar
• Sell S. Cancer markers of the 1990s. Clinics Lab Med 1990; 10: 1–37
   PubMedGoogle Scholar
• Börmer O. A direct assay for carcinoembryonic antigen in serum and its diagnostic value in metastatic breast cancer. Clin Biochem 1982; 15: 128–32
   PubMed Web of Science ®Google Scholar
• Börmer O P., Nustad K. Selection of monoclonal antibodies for use in an immunometric assay for carcinoembryonic antigen. J Immunol Methods 1990; 127: 171–8
   PubMed Web of Science ®Google Scholar
• Laurence D JR, Turberville C, Anderson S G., Neville A M. First British standard for carcino-embryonic antigen (CEA). Br J Cancer 1975; 32: 295–9
   PubMed Web of Science ®Google Scholar
• Börmer O P. Standardization, specificity, and diagnostic sensitivity of four immunoassays for carcinoemhryonic antigen. Clin Chem 1991; 37: 231–6
   PubMedGoogle Scholar
• Riesen W, Kessler A C., Ehrhardt V. Individual variations of carcinoemhryonic antigen (CEA) in serum of healthy subjects. Clin Chem 1987; 33: 2123
   PubMedGoogle Scholar
• Clarke C, Hine K R., Dykes P W., Whitehead T P., Whitfield A GW. Carcinoemhryonic antigen and smoking. J Royal College of Physicians 1980; 14: 227–8
   PubMedGoogle Scholar
• Jean F, Malapert P, Rougon G, Barbet J. Cell membrane, but not circulating, carcinoemhryonic antigen is linked to a phosphatidylinositol-containing hydrophobic domain. Biochem Biophys Res Commun 1988; 155: 794–800
   PubMedGoogle Scholar
• Börmer O P., Thrane-Steen K. Epitope group specificity of six immunoassays for carcinoemhryonic antigen. Tumor Biol 1991; 12: 9–15
   PubMedGoogle Scholar
• Gold P. Circulating antibodies against carcino-emhryonic antigens of the human digestive system. Cancer 1967; 20: 1663–7
   Web of Science ®Google Scholar
• Pompecki R, Shively J E., Todd C W. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoemhryonic antigen-polyethylene glycol immunoassay. Cancer Res 1981; 41: 1910–15
   Google Scholar
• Börmer O P. Interference of complement with the binding of carcinoemhryonic antigen to solid-phase monoclonal antibodies. J Immunol Methods 1989; 121: 85–93
   PubMed Web of Science ®Google Scholar
• Käpyaho K, Tanner P, Weber T. Effect of complement on a solid-phase immunometric TSH assay. Scand J Clin Lab Invest 1989; 49: 211–16
   PubMed Web of Science ®Google Scholar
• Boscato L M., Stuart M C. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491–5
   PubMed Web of Science ®Google Scholar
• Seth R, Raymond F D., Makgoba M W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 83–4
   PubMed Web of Science ®Google Scholar
• Lindmo T, Børmer O, Ugelstad J, Nustad K. Immunometric assay by flow cytometry using mixtures of two particle types of different affinity. J Immunol Methods 1990; 126: 183–9
   PubMed Web of Science ®Google Scholar